(Q47794929)

5 February 2018

title

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice. (English)

1 reference

5 February 2018

0 references

0 references

5

1 reference

5 February 2018

Jac Kee Low

object named as

Jac Kee Low

2

0 references

author name string

David Cheng

1

1 reference

5 February 2018

Warren Logge

3

1 reference

5 February 2018

Brett Garner

4

1 reference

5 February 2018

publication date

1 March 2014

1 reference

5 February 2018

published in

Psychopharmacology

1 reference

5 February 2018

volume

231

1 reference

5 February 2018

issue

15

1 reference

5 February 2018

page(s)

3009-3017

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-014-3478-5

exact match

0 references

cites work

Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The endocannabinoid system and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Novel behavioural characteristics of the APP(Swe)/PS1ΔE9 transgenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cognition in female transmembrane domain neuregulin 1 mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cognition in transmembrane domain neuregulin 1 mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

In vivo hippocampal microdialysis reveals impairment of NMDA receptor-cGMP signaling in APP(SW) and APP(SW)/PS1(L166P) Alzheimer's transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Anxiogenic-like effects of chronic cannabidiol administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Thy1-hAPP(Lond/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Animal models of Alzheimer's disease and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Antianxiety effect of cannabidiol in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Phytocannabinoids as novel therapeutic agents in CNS disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol: a promising drug for neurodegenerative disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Inflammation and white matter degeneration persist for years after a single traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1ΔE9 double transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Behavioural profile of a new mouse model for NPY deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cognitive phenotyping of amyloid precursor protein transgenic J20 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The therapeutic potential of the endocannabinoid system for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabinoids for the treatment of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Role of Abca7 in mouse behaviours relevant to neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Inflammation and aging: can endocannabinoids help?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Endocannabinoids and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The relation between fear induced by novel stimulation and exploratory drive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Glutamate and other CSF amino acids in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsiv

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3478-5

Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.

21 January 2018

1 reference

12 December 2020

The relation between fear and exploratory behavior.

1 reference

12 December 2020

The relation between fear induced by novel stimulation and exploratory behavior.

1 reference

12 December 2020

Pharmacological characterization of cannabinoids in the elevated plus maze

1 reference

12 December 2020

Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease.

1 reference

12 December 2020

Targeting the endocannabinoid system in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00213-014-3478-5

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

24577515

1 reference

5 February 2018